NewslettersCell Therapy NewsUncategorizedCD19/BAFF-R Dual-Targeted CAR T Cells for the Treatment of Mixed Antigen-Negative Variants of Acute Lymphoblastic LeukemiaBy Justin.choi - January 18, 20220155To mitigate antigen escape and potentially improve the durability of remission, scientists developed a dual-targeting approach using an optimized, bispecific CAR construct that targets both CD19 and BAFF-R.[Leukemia] 6445212 AAAAAAAA items 1 apa 0 default asc 1 170814 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Abstract